DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

0
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Popular News

CymaBay Therapeutics Inc. (NASDAQ:CBAY) Announce Its Q3 2020 Results And Progress...

0
CymaBay Therapeutics Inc. (NASDAQ:CBAY) has announced its financial results for Q3  2020 and nine months ended September 30, 2020, and provided corporate updates. CymaBay’s ENHANCE...

MAKE IT MODERN

LATEST REVIEWS

Biotech Stocks In Focus, Top biotech stocks

S&P 500 could move higher as per technical analysis (ARM, S&P)

0
We broke through the 50 SMA yesterday with a strong move higher as SPY closed up nearly $4 per share. Next chart...

MAKE IT MODERN

PERFORMANCE TRAINING

DS-100 is the Fifth Drug Application Under FDA Review Of Eton Pharmaceuticals Inc. (NASDAQ:ETON),...

0
Through the introduction of innovative medicines, Eton Pharmaceuticals Inc. (NASDAQ:ETON) has taken up the responsibility of advancing the healthcare sector. This is in addition...

Skillz Inc (NYSE: SKLZ) Reports $85.9 Million Net Revenue in The Second Quarter...

0
Skillz Inc (NYSE: SKLZ), a leading mobile games platform, recently announced its financial results for the three months that ended on June 30, 2021....

Pharvaris NV (NASDAQ: PHVS) could surge more than 20% from current levels

0
Pharvaris NV (NASDAQ: PHVS) last traded at $9.05, down 2.69%. The company has been in the limelight thanks to topline data from the...

ISW Holdings Inc (OTCMKTS:ISWH) Bets on High-Growth Diversification

0
In building the case for diversified small caps, such as ISW Holdings Inc (OTCMKTS:ISWH), you have to paint a picture that shows credible promise...

CNS Pharmaceuticals Inc. (NASDAQ:CNSP) Announces its Plans for its Lead Product Candidate, Berubicin

0
CNS Pharmaceuticals Inc. (NASDAQ:CNSP) has its lead product candidate, Berubicin being studied for the treatment of glioblastoma multiforme (GBM). A couple of months ago,...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد